Moreover, a ROC curve was used to analyze the effectiveness of SLC22A8 expression in paraneoplastic tissues, ccRCC samples, and normal samples of GTEx combined with adjacent ccRCC tissues and ccRCC samples. Here, SLC22A8 is linked to nonpapillary renal cell carcinoma.